Analysis of the Radiation Safety Climate in the Hybrid Angiography Suite

November 24, 2021 updated by: University Ghent

Analysis of the Radiation Safety Climate in the Hybrid Angiography Suite and Its Effects on Radiation Safety Performance

This study aims to measure the radiation safety climate in the hybrid angiography suite using self-assessment and to investigate the relationship of radiation safety climate with their self-reported safety behaviors.

The hypothesis is that a radiation safety climate does exist and can be measured using self-assessment. Additionally, it is expected that the radiation safety climate positively influences radiation safety behaviors.

Study Overview

Detailed Description

Radiation safety in the hybrid angiography suite is a primordial safety component which is relevant for endovascular team members and patients. To date, many interventions which aim to improve radiation safety habits of an endovascular team focus on improving technology and team radiation safety knowledge. Safety literature has indicated that a safety climate can be identified as the shared perceptions of team members or workers about the safety in their workspace and that this safety climate is closely related to safety behaviors and outcomes. In endovascular specialties, the concept of a radiation safety climate remains unexplored. Therefore, this study aims to measure the radiation safety climate in a diverse pool of endovascular team members from different hospitals, using self-assessment questionnaires and to investigate the relationship of radiation safety climate with their self-reported safety behaviors.

Study Type

Observational

Enrollment (Actual)

92

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antwerpen, Belgium, 2610
        • GZA Campus Sint Augustinus
    • Oost Vlaanderen
      • Ghent, Oost Vlaanderen, Belgium, 9000
        • Algemeen Ziekenhuis Maria Middelares
      • Ghent, Oost Vlaanderen, Belgium, 9000
        • Ghent University Hospital
    • West Vlaanderen
      • Brugge, West Vlaanderen, Belgium, 8000
        • Az Sint Jan Brugge
      • Ieper, West Vlaanderen, Belgium, 8900
        • Jan Yperman Ziekenhuis

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

  • Endovascular team members: vascular surgeons, surgical trainees, operating nurses
  • Patients undergoing elective endovascular repair of infrarenal abdominal aortic aneurysm

Description

Endovascular team member group

Inclusion Criteria:

  • Vascular surgeon OR surgical trainee OR operating nurse
  • Active at one of the participating hospitals

Exclusion Criteria:

  • No exclusion criteria apply to this study.

Patient group Inclusion Criteria

  • Patient undergoing elective endovascular repair of infrarenal abdominal aortic aneurysm

Exclusion criteria

  • Emergency repair (ruptured aneurysm)
  • Additional interventional procedures (iliac aneurysm, treatment of peripheral vessel disease)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Endovascular team members

All vascular surgeons, surgical trainees, nurses active in the hybrid angiography suite at one of the participating centers will be invited to participate in the study.

All participating team members complete an online questionnaire containing an assessment of their perceived radiation safety climate (28 items, 5 dimensions), radiation safety behaviors(2 items, 2 dimensions), radiation safety knowledge (single item) and radiation safety motivation (single item). All data will be stored pseudonymized.

The rating tool contains 28 statements which cover 5 dimensions (Leadership, communication, commitment, resources, risk awareness) of the radiation safety climate. Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement. A composite radiation safety climate score is calculated by adding ratings on all items.

Minimum scale score 28 - Maximum scale score 140

Other Names:
  • Radiation safety climate rating tool
The rating tool contains 2 statements which cover 2 dimensions of the radiation safety behavior. Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement. A composite radiation safety behavior score is calculated by adding ratings on both items Minimum scale score 2 - Maximum scale score 10
Other Names:
  • Radiation safety behavior rating tool

The rating tool contains 2 statements which cover the radiation safety knowledge and behavior. Participants are asked to indicate on a scale of 1 (completely disagree) - 3 (neutral) - 5 (completely agree) whether they agree with each statement.

Minimum item score 1 - maximum item score 5

Other Names:
  • Radiation safety knowledge and motivation rating tool
Vascular surgical patients

In each center, five patients undergoing primary elective endovascular repair for an infrarenal abdominal aortic aneurysm (EVAR) will be enrolled in the study.

For each participating patient, a set of demographical (BMI, case difficulty, ASA-grade,etc.), procedure-related (procedure duration, contrast use, etc.) and radiation dose parameters (DAP, cumulative air kerma) will be collected and stored in a pseudonymized way.

Participation in this study has no effect on the interventional procedure, or the chosen approach.

Collection of patient-related data points Demographic information: ASA-classification, BMI Procedure related information: Procedural time, approach, contrast usage case difficulty Radiation safety parameters: Air Kerma, DAP, fluoroscopy time

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-assessed radiation safety climate
Time Frame: Baseline measurement on study inclusion (Day 1)
Radiation safety climate using radiation safety climate tool
Baseline measurement on study inclusion (Day 1)
Self-assessed radiation safety behavior
Time Frame: Baseline measurement on study inclusion (Day 1)
Radiation safety behavior using radiation safety behavior tool
Baseline measurement on study inclusion (Day 1)
Self-assessed radiation safety knowledge and motivation
Time Frame: Baseline measurement on study inclusion (Day 1)
Radiation safety knowledge and motivation using rating tool
Baseline measurement on study inclusion (Day 1)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Procedural radiation doses - Dose area product
Time Frame: Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
Procedural dose area product (DAP)
Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
Procedural radiation doses - cumulative air kerma
Time Frame: Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
Procedural cumulative air kerma (CAK)
Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
Procedural radiation doses - fluoroscopy time
Time Frame: Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion
Procedural fluoroscopy time
Registration during endovascular EVAR procedure - Within 1 week after patient study inclusion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 24, 2019

Primary Completion (ACTUAL)

August 20, 2019

Study Completion (ACTUAL)

August 20, 2019

Study Registration Dates

First Submitted

August 14, 2019

First Submitted That Met QC Criteria

August 19, 2019

First Posted (ACTUAL)

August 21, 2019

Study Record Updates

Last Update Posted (ACTUAL)

December 8, 2021

Last Update Submitted That Met QC Criteria

November 24, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Research data will not be shared standard

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Volunteers

Clinical Trials on Assessment of radiation safety climate

Subscribe